找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

(版塊ONCOLOGY(腫瘤學(xué))版塊期刊總數(shù):80)
新窗
投票 ESCI期刊Indian Journal of Surgical Oncology 2024/2025影響因子:0.669 (INDIA J SURG ONCOL) (0975-7651). (ONCOLOGY)(腫瘤學(xué))Emerging  ...234
Total Citations:999; 2023 JIF:0.669; JIFRank: 299/322 ; Rank-JIF: 299; Number-of-JIF:322; 5 Year JIF:0.767; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.6; Immediacy Index:0.1; Immediacy Index-dealt:0.185; 2023 JCI:0.11; JCI Rank: 302/322 ; Total Articles:125; JCI Quartile:Q4; JCI Percentile:6.37; Eigenfactor:0.001; Normalized Eigenfactor:0.298; Article Influence Score:0.188; JIF Percentile:7.3; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:159; % of Articles in Citable items:0.7862; Cited Half-Life:4.8; Citing Half-Life:10.2; % of OA Gold:0.0327; Publisher name:WILEY; Publisher address:111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774;
投票 ESCI期刊Indian Journal of Medical and Paediatric Oncology 2024/2025影響因子:0.366 (INDIAN J MED PAEDIAT) (0971-5851). (ONCOLO  ...234
Total Citations:779; 2023 JIF:0.366; JIFRank: 309/322 ; Rank-JIF: 309; Number-of-JIF:322; 5 Year JIF:0.331; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.3; Immediacy Index:0.1; Immediacy Index-dealt:0.129; 2023 JCI:0.04; JCI Rank: 315/322 ; Total Articles:38; JCI Quartile:Q4; JCI Percentile:2.33; Eigenfactor:0; Normalized Eigenfactor:0.075; Article Influence Score:0.075; JIF Percentile:4.2; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:122; % of Articles in Citable items:0.3115; Cited Half-Life:7.7; Citing Half-Life:8.2; % of OA Gold:0.9931; Publisher name:ACADEMIC PRESS INC ELSEVIER SCIENCE; Publisher address:525 B ST, STE 1900, SAN DI
投票 ESCI期刊Molecular and Clinical Oncology 2024/2025影響因子:1.402 (MOL CLIN ONCOL) (2049-9450). (ONCOLOGY)(腫瘤學(xué))Emerging Sources  ...234
Total Citations:2984; 2023 JIF:1.402; JIFRank: 263/322 ; Rank-JIF: 263; Number-of-JIF:322; 5 Year JIF:1.337; 5 Year JIF Quartile:Q4; JIF Without Self Cites:1.4; Immediacy Index:0.3; Immediacy Index-dealt:0.311; 2023 JCI:0.29; JCI Rank: 276/322 ; Total Articles:81; JCI Quartile:Q4; JCI Percentile:14.44; Eigenfactor:0.003; Normalized Eigenfactor:0.686; Article Influence Score:0.344; JIF Percentile:18.5; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:101; % of Articles in Citable items:0.802; Cited Half-Life:6; Citing Half-Life:7.5; % of OA Gold:0.9961; Publisher name:PENN STATE UNIV PRESS; Publisher address:820 NORTH UNIV DRIVE, U S B 1, STE C
投票 ESCI期刊Blood Cancer Discovery 2024/2025影響因子:11.541 (BLOOD CANCER DISCOV) (2643-3230). (ONCOLOGY)(腫瘤學(xué))Emerging Sources Ci  ...234
Total Citations:1059; 2023 JIF:11.541; JIFRank: 24/322 ; Rank-JIF: 24; Number-of-JIF:322; 5 Year JIF:11.164; 5 Year JIF Quartile:Q1; JIF Without Self Cites:11.3; Immediacy Index:3.6; Immediacy Index-dealt:3.637; 2023 JCI:2.55; JCI Rank: 19/322 ; Total Articles:20; JCI Quartile:Q1; JCI Percentile:94.25; Eigenfactor:0.004; Normalized Eigenfactor:0.98; Article Influence Score:6.145; JIF Percentile:92.7; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:23; % of Articles in Citable items:0.8696; Cited Half-Life:2.2; Citing Half-Life:6.8; % of OA Gold:0.3548; Publisher name:NATL TAIWAN UNIV PRESS; Publisher address:NO 1 SECTION 4, ROOSEVELT RD, TAIP
投票 ESCI期刊Molecular & Cellular Oncology 2024/2025影響因子:2.635 (MOL CELL ONCOL) (NULL). (ONCOLOGY)(腫瘤學(xué))Emerging Sources Citati  ...234
Total Citations:1159; 2023 JIF:2.635; JIFRank: 175/322 ; Rank-JIF: 175; Number-of-JIF:322; 5 Year JIF:1.696; 5 Year JIF Quartile:Q4; JIF Without Self Cites:2.6; Immediacy Index:0.3; Immediacy Index-dealt:0.395; 2023 JCI:0.24; JCI Rank: 282/322 ; Total Articles:4; JCI Quartile:Q4; JCI Percentile:12.58; Eigenfactor:0.001; Normalized Eigenfactor:0.237; Article Influence Score:0.463; JIF Percentile:45.8; JIF Quartile:Q3; AIS Quartile:Q4; Citable Items:4; % of Articles in Citable items:1; Cited Half-Life:7.2; Citing Half-Life:7.6; % of OA Gold:0.5227; Publisher name:SAGE PUBLICATIONS INC; Publisher address:2455 TELLER RD, THOUSAND OAKS, USA, CA, 9
投票 ESCI期刊JNCI Cancer Spectrum 2024/2025影響因子:3.439 (JNCI CANCER SPECT) (NULL). (ONCOLOGY)(腫瘤學(xué))Emerging Sources Citation Ind  ...234
Total Citations:1963; 2023 JIF:3.439; JIFRank: 110/322 ; Rank-JIF: 110; Number-of-JIF:322; 5 Year JIF:4.231; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.4; Immediacy Index:1.9; Immediacy Index-dealt:1.927; 2023 JCI:0.82; JCI Rank: 109/322 ; Total Articles:83; JCI Quartile:Q2; JCI Percentile:66.3; Eigenfactor:0.008; Normalized Eigenfactor:1.639; Article Influence Score:2.16; JIF Percentile:66; JIF Quartile:Q2; AIS Quartile:Q1; Citable Items:90; % of Articles in Citable items:0.9222; Cited Half-Life:3.3; Citing Half-Life:5.9; % of OA Gold:0.9496; Publisher name:ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD; Publisher address:2-4 PARK SQUARE, MI
投票 ESCI期刊Eurasian Journal of Medicine and Oncology 2024/2025影響因子:0.831 (EURASIAN J MED ONCOL) (NULL). (ONCOLOGY)(腫瘤學(xué))Emerg  ...234
Total Citations:211; 2023 JIF:0.831; JIFRank: 296/322 ; Rank-JIF: 296; Number-of-JIF:322; 5 Year JIF:0.826; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.8; Immediacy Index:0.1; Immediacy Index-dealt:0.187; 2023 JCI:0.36; JCI Rank: 255/322 ; Total Articles:35; JCI Quartile:Q4; JCI Percentile:20.96; Eigenfactor:0; Normalized Eigenfactor:0.062; Article Influence Score:0.147; JIF Percentile:8.2; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:45; % of Articles in Citable items:0.7778; Cited Half-Life:3.3; Citing Half-Life:7; % of OA Gold:0.9248; Publisher name:SPRINGER; Publisher address:ONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, United State
投票 ESCI期刊Lung Cancer-Targets and Therapy 2024/2025影響因子:5.163 (LUNG CANCER-TARGETS) (NULL). (ONCOLOGY)(腫瘤學(xué))Emerging Sources  ...234
Total Citations:429; 2023 JIF:5.163; JIFRank: 65/322 ; Rank-JIF: 65; Number-of-JIF:322; 5 Year JIF:3.891; 5 Year JIF Quartile:Q2; JIF Without Self Cites:5.1; Immediacy Index:2; Immediacy Index-dealt:2.155; 2023 JCI:0.6; JCI Rank: 177/322 ; Total Articles:5; JCI Quartile:Q3; JCI Percentile:45.19; Eigenfactor:0; Normalized Eigenfactor:0.102; Article Influence Score:0.926; JIF Percentile:80; JIF Quartile:Q1; AIS Quartile:Q2; Citable Items:7; % of Articles in Citable items:0.7143; Cited Half-Life:5.4; Citing Half-Life:4.9; % of OA Gold:0.8889; Publisher name:TURKISH SOC THERMAL SCIENCES TECHNOLOGY; Publisher address:TIBTD MAKINA MUHENDISLIGI BOLU
投票 ESCI期刊Chinese Clinical Oncology 2024/2025影響因子:2.135 (CHIN CLIN ONCOL) (2304-3865). (ONCOLOGY)(腫瘤學(xué))Emerging Sources Cita  ...234
Total Citations:1219; 2023 JIF:2.135; JIFRank: 214/322 ; Rank-JIF: 214; Number-of-JIF:322; 5 Year JIF:2.983; 5 Year JIF Quartile:Q3; JIF Without Self Cites:2; Immediacy Index:0.5; Immediacy Index-dealt:0.597; 2023 JCI:0.28; JCI Rank: 277/322 ; Total Articles:19; JCI Quartile:Q4; JCI Percentile:14.13; Eigenfactor:0.001; Normalized Eigenfactor:0.302; Article Influence Score:0.666; JIF Percentile:33.7; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:62; % of Articles in Citable items:0.3065; Cited Half-Life:5.2; Citing Half-Life:5.1; % of OA Gold:0.9058; Publisher name:MDPI; Publisher address:ST ALBAN-ANLAGE 66, BASEL, SWITZERLAND, CH-4052;
投票 ESCI期刊JCO Global Oncology 2024/2025影響因子:3.273 (JCO GLOB ONCOL) (NULL). (ONCOLOGY)(腫瘤學(xué))Emerging Sources Citation Index  ...234
Total Citations:1960; 2023 JIF:3.273; JIFRank: 129/322 ; Rank-JIF: 129; Number-of-JIF:322; 5 Year JIF:3.982; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.1; Immediacy Index:0.7; Immediacy Index-dealt:0.792; 2023 JCI:0.74; JCI Rank: 133/322 ; Total Articles:106; JCI Quartile:Q2; JCI Percentile:58.85; Eigenfactor:0.005; Normalized Eigenfactor:1.138; Article Influence Score:1.308; JIF Percentile:60.1; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:127; % of Articles in Citable items:0.8346; Cited Half-Life:2.9; Citing Half-Life:5.8; % of OA Gold:0.8941; Publisher name:WOLTERS KLUWER MEDKNOW PUBLICATIONS; Publisher address:WOLTERS KLUWER IND
投票 ESCI期刊Gaceta Mexicana de Oncologia 2024/2025影響因子:0.074 (GAC MEX ONCOL) (1665-9201). (ONCOLOGY)(腫瘤學(xué))Emerging Sources Cit  ...234
Total Citations:42; 2023 JIF:0.074; JIFRank: 322/322 ; Rank-JIF: 322; Number-of-JIF:322; 5 Year JIF:0.136; 5 Year JIF Quartile:Q4; JIF Without Self Cites:<0.1; Immediacy Index:<0.1; Immediacy Index-dealt:0.057; 2023 JCI:0.01; JCI Rank: 322/322 ; Total Articles:37; JCI Quartile:Q4; JCI Percentile:0.16; Eigenfactor:0; Normalized Eigenfactor:0.003; Article Influence Score:0.008; JIF Percentile:0.2; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:45; % of Articles in Citable items:0.8222; Cited Half-Life:NULL; Citing Half-Life:8.6; % of OA Gold:0.9793; Publisher name:VERLAG KIRCHHEIM; Publisher address:POSTFACH 25 24, MAINZ, GERMANY, 55015;
投票 ESCI期刊Journal of Cancer Epidemiology 2024/2025影響因子:1.886 (J CANCER EPIDEMIOL) (1687-8558). (ONCOLOGY)(腫瘤學(xué))Emerging Sour  ...234
Total Citations:443; 2023 JIF:1.886; JIFRank: 241/322 ; Rank-JIF: 241; Number-of-JIF:322; 5 Year JIF:2.52; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.8; Immediacy Index:<0.1; Immediacy Index-dealt:0.074; 2023 JCI:0.37; JCI Rank: 251/322 ; Total Articles:3; JCI Quartile:Q4; JCI Percentile:22.2; Eigenfactor:0; Normalized Eigenfactor:1.252; Article Influence Score:0.638; JIF Percentile:25.3; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:3; % of Articles in Citable items:1; Cited Half-Life:9.7; Citing Half-Life:10.6; % of OA Gold:1; Publisher name:ROYAL SOC CHEMISTRY; Publisher address:THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRID
投票 ESCI期刊Journal of Breast Imaging 2024/2025影響因子:2.123 (J BREAST IMAGING) (2631-6110). (ONCOLOGY)(腫瘤學(xué))Emerging Sources Cit  ...234
Total Citations:603; 2023 JIF:2.123; JIFRank: 221/322 ; Rank-JIF: 221; Number-of-JIF:322; 5 Year JIF:1.889; 5 Year JIF Quartile:Q4; JIF Without Self Cites:1.4; Immediacy Index:1.4; Immediacy Index-dealt:1.472; 2023 JCI:0.42; JCI Rank: 232/322 ; Total Articles:58; JCI Quartile:Q3; JCI Percentile:32.11; Eigenfactor:0.001; Normalized Eigenfactor:0.21; Article Influence Score:0.43; JIF Percentile:49.3; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:76; % of Articles in Citable items:0.7632; Cited Half-Life:2.5; Citing Half-Life:6.9; % of OA Gold:0.0833; Publisher name:RUSSIAN PRESIDENTIAL ACAD NATL ECONOMY & PUBLIC ADM (RANEPA); Publisher addres
投票 ESCI期刊Oncology and Therapy 2024/2025影響因子:3.222 (ONCOL THER) (2366-1070). (ONCOLOGY)(腫瘤學(xué))Emerging Sources Citation Index  ...234
Total Citations:476; 2023 JIF:3.222; JIFRank: 129/322 ; Rank-JIF: 129; Number-of-JIF:322; 5 Year JIF:3.292; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.2; Immediacy Index:0.5; Immediacy Index-dealt:0.533; 2023 JCI:0.45; JCI Rank: 225/322 ; Total Articles:19; JCI Quartile:Q3; JCI Percentile:30.28; Eigenfactor:0.001; Normalized Eigenfactor:0.188; Article Influence Score:0.857; JIF Percentile:60.1; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:26; % of Articles in Citable items:0.7308; Cited Half-Life:2.9; Citing Half-Life:5.1; % of OA Gold:1; Publisher name:NULL; Publisher address:NULL;
投票 ESCI期刊Physics & Imaging in Radiation Oncology 2024/2025影響因子:3.411 (PHYS IMAG RADIAT ONC) (NULL). (ONCOLOGY)(腫瘤學(xué))Emergin  ...234
Total Citations:1349; 2023 JIF:3.411; JIFRank: 110/322 ; Rank-JIF: 110; Number-of-JIF:322; 5 Year JIF:3.474; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2.6; Immediacy Index:0.9; Immediacy Index-dealt:0.968; 2023 JCI:0.92; JCI Rank: 88/322 ; Total Articles:114; JCI Quartile:Q2; JCI Percentile:74.26; Eigenfactor:0.002; Normalized Eigenfactor:0.487; Article Influence Score:0.766; JIF Percentile:80.6; JIF Quartile:Q1; AIS Quartile:Q2; Citable Items:115; % of Articles in Citable items:0.9913; Cited Half-Life:2.9; Citing Half-Life:5; % of OA Gold:0.8144; Publisher name:SPRINGER; Publisher address:VAN GODEWIJCKSTRAAT 30, DORDRECHT, NETHERLANDS,
投票 ESCI期刊Advances in Radiation Oncology 2024/2025影響因子:2.234 (ADV RADIAT ONCOL) (NULL). (ONCOLOGY)(腫瘤學(xué))Emerging Sources Cit  ...234
Total Citations:2224; 2023 JIF:2.234; JIFRank: 209/322 ; Rank-JIF: 209; Number-of-JIF:322; 5 Year JIF:2.433; 5 Year JIF Quartile:Q3; JIF Without Self Cites:2.1; Immediacy Index:0.7; Immediacy Index-dealt:0.722; 2023 JCI:0.63; JCI Rank: 169/322 ; Total Articles:135; JCI Quartile:Q2; JCI Percentile:51.72; Eigenfactor:0.005; Normalized Eigenfactor:1.037; Article Influence Score:0.748; JIF Percentile:55.6; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:144; % of Articles in Citable items:0.9375; Cited Half-Life:3.3; Citing Half-Life:7.3; % of OA Gold:0.8154; Publisher name:SCIENDO; Publisher address:BOGUMILA ZUGA 32A, WARSAW, Poland, MAZOVIA, 01
投票 ESCI期刊Blood and Lymphatic Cancer-Targets and Therapy 2024/2025影響因子:3.943 (BLOOD LYMPHAT CANCER) (1179-9889). (ONCOLOGY)  ...234
Total Citations:138; 2023 JIF:3.943; JIFRank: 99/322 ; Rank-JIF: 99; Number-of-JIF:322; 5 Year JIF:3.303; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.9; Immediacy Index:0.6; Immediacy Index-dealt:0.642; 2023 JCI:0.57; JCI Rank: 188/322 ; Total Articles:2; JCI Quartile:Q3; JCI Percentile:41.77; Eigenfactor:0; Normalized Eigenfactor:0.052; Article Influence Score:0.863; JIF Percentile:69.4; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:7; % of Articles in Citable items:0.2857; Cited Half-Life:2.7; Citing Half-Life:6.5; % of OA Gold:1; Publisher name:ELSEVIER SCIENCE INC; Publisher address:STE 800, 230 PARK AVE, NEW YORK, USA, NY, 10169;
投票 ESCI期刊Oncology Reviews 2024/2025影響因子:3.199 (ONCOL REV) (1970-5557). (ONCOLOGY)(腫瘤學(xué))Emerging Sources Citation Index  ...234
Total Citations:663; 2023 JIF:3.199; JIFRank: 136/322 ; Rank-JIF: 136; Number-of-JIF:322; 5 Year JIF:3.456; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.1; Immediacy Index:0.2; Immediacy Index-dealt:0.255; 2023 JCI:0.45; JCI Rank: 225/322 ; Total Articles:1; JCI Quartile:Q3; JCI Percentile:30.28; Eigenfactor:0.001; Normalized Eigenfactor:0.117; Article Influence Score:0.772; JIF Percentile:57.9; JIF Quartile:Q2; AIS Quartile:Q3; Citable Items:10; % of Articles in Citable items:0.1; Cited Half-Life:6.3; Citing Half-Life:8.8; % of OA Gold:1; Publisher name:NULL; Publisher address:NULL;
投票 ESCI期刊Reports of Practical Oncology and Radiotherapy 2024/2025影響因子:1.272 (REP PRACT ONCOL RADI) (1507-1367). (ONCOLOGY)  ...234
Total Citations:1361; 2023 JIF:1.272; JIFRank: 273/322 ; Rank-JIF: 273; Number-of-JIF:322; 5 Year JIF:1.457; 5 Year JIF Quartile:Q4; JIF Without Self Cites:1; Immediacy Index:0.1; Immediacy Index-dealt:0.149; 2023 JCI:0.3; JCI Rank: 274/322 ; Total Articles:72; JCI Quartile:Q4; JCI Percentile:22.3; Eigenfactor:0.001; Normalized Eigenfactor:0.288; Article Influence Score:0.285; JIF Percentile:27.2; JIF Quartile:Q3; AIS Quartile:Q4; Citable Items:86; % of Articles in Citable items:0.8372; Cited Half-Life:5; Citing Half-Life:8.8; % of OA Gold:0.0575; Publisher name:SAGE PUBLICATIONS LTD; Publisher address:1 OLIVERS YARD, 55 CITY ROAD, LONDON, EN
投票 ESCI期刊Case Reports in Oncological Medicine 2024/2025影響因子:0.618 (CASE REP ONCOL MED) (2090-6706). (ONCOLOGY)(腫瘤學(xué))Emergin  ...234
Total Citations:492; 2023 JIF:0.618; JIFRank: 299/322 ; Rank-JIF: 299; Number-of-JIF:322; 5 Year JIF:0.898; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.6; Immediacy Index:0.1; Immediacy Index-dealt:0.126; 2023 JCI:0.15; JCI Rank: 298/322 ; Total Articles:8; JCI Quartile:Q4; JCI Percentile:7.61; Eigenfactor:0; Normalized Eigenfactor:0.088; Article Influence Score:0.185; JIF Percentile:7.3; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:10; % of Articles in Citable items:0.8; Cited Half-Life:7.1; Citing Half-Life:7.6; % of OA Gold:0.9796; Publisher name:KOREAN BIOCHIP SOCIETY-KBCS; Publisher address:KOREA SCI & TECHNOL CENT, #310, 635-4,
下一頁 »
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-5 01:02
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
返回頂部 返回版塊
田东县| 阿拉善左旗| 深圳市| 宜昌市| 临西县| 隆安县| 新源县| 汾阳市| 通许县| 宁波市| 米易县| 山西省| 中超| 裕民县| 新田县| 泗阳县| 蚌埠市| 石楼县| 河池市| 寻甸| 丰顺县| 鸡西市| 清涧县| 日照市| 汉阴县| 湖口县| 裕民县| 乌拉特后旗| 高密市| 华阴市| 呼伦贝尔市| 台江县| 卓资县| 满洲里市| 全州县| 衡山县| 彭州市| 韶关市| 丰城市| 卓资县| 山丹县|